Lasa Supergenerics Company Description

Lasa Supergenerics Limited engages in the manufacturing API bulk drugs products in India and internationally.

It offers API products, such as fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, 2,6-diiodo-4-nitrophenol, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide; and Other API products.

The company also provides animal feed ingredients; and reagents for therapeutic use. In addition, it exports its products.

Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Lasa Supergenerics Limited

Country	India
Founded	2016
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	9
CEO	Omkar Herlekar

Contact Details

Address: Plot no. C-4 Ratnagiri, 415722 India
Phone	91 77 9888 8147
Website	lasalabs.com

Stock Details

Ticker Symbol	LASA
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE670X01014
SIC Code	2833

Key Executives

Name	Position
Dr. Omkar Pravin Herlekar	Chairman and MD
Varsha Pravin Joshi	Chief Financial Officer
Anil Fargade	Senior Accounts Officer
Sunil Sitale	Manager of Human Resources and Admin